Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OCTRU is a registered UKCRC Clinical Trials Unit. Based within the University of Oxford, the unit works closely with the Oxford Trauma, Oncology Clinical Trials Office, Surgical Intervention Trials Unit and Rehabilitation Research in Oxford groups.

6 image

The Oxford Clinical Trials Research Unit (OCTRU) has integrated several trials groups from across Oxford and working in different therapeutic areas into a single UKCRC registered Clinical Trials Unit (CTU).

OCTRU aims to design, conduct and report in both early and later phase clinical trials predominately in surgery, musculo-skeletal sciences and oncology.

We focus in particular on development pathways and the evaluation of new health technologies in:

  • surgery and interventional procedures (including anaesthetics, surgical procedures, pre- and post-surgical care)
  • trauma, rehabilitation and conservative management
  • pharmaceuticals and imaging modalities 

OCTRU was given full UKCRC Clinical Trial Unit status in August 2012 and officially launched in July 2013.

In October 2014 OCTRU was awarded National Cancer Research Institute (NCRI) CTU status.

OCTRU formally became part of CSM in March 2017, prior to this the relationship between CSM and OCTRU had been close but never formalised.

Click here to find details of the OCTRU hub team and the theme leaders within OCTRU.

Click here to find details of how to collaborate with OCTRU.